Results 1 to 10 of about 95,693 (243)

The promises of quantitative systems pharmacology modelling for drug development

open access: yesComputational and Structural Biotechnology Journal, 2016
Recent growth in annual new therapeutic entity (NTE) approvals by the U.S. Food and Drug Administration (FDA) suggests a positive trend in current research and development (R&D) output.
V.R. Knight-Schrijver   +3 more
doaj   +5 more sources

A Review of Quantitative Systems Pharmacology Models of the Coagulation Cascade: Opportunities for Improved Usability

open access: yesPharmaceutics, 2023
Despite the numerous therapeutic options to treat bleeding or thrombosis, a comprehensive quantitative mechanistic understanding of the effects of these and potential novel therapies is lacking. Recently, the quality of quantitative systems pharmacology (
Douglas Chung   +2 more
doaj   +3 more sources

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
The development and application of quantitative systems pharmacology models in neuroscience have been modest relative to other fields, such as oncology and immunology, which may reflect the complexity of the brain.
Peter Bloomingdale   +7 more
doaj   +3 more sources

Quantitative systems pharmacology model of B cell immune response in mouse [PDF]

open access: yesFrontiers in Immunology
B cell-mediated immunity plays a crucial role in long-term humoral protection. However, dysregulation of B cell development and differentiation may lead to the persistence of autoreactive clones, contributing to autoimmune diseases.
Yaroslav Ugolkov   +10 more
doaj   +2 more sources

Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B‐Cell Malignancies [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology
The effectiveness of Bruton tyrosine kinase (BTK) inhibitors is influenced by the level of BTK occupancy in target tissues. In randomized phase 3 studies, progression‐free survival (PFS) with zanubrutinib was superior to ibrutinib, whereas acalabrutinib ...
Oleg Demin Jr   +10 more
doaj   +2 more sources

The Emerging Discipline of Quantitative Systems Pharmacology [PDF]

open access: yesFrontiers in Pharmacology, 2015
Quantitative Systems Pharmacology (QSP) has emerged recently as an approach that integrates knowledge coming from multiple disciplines including drug pharmacology, systems biology, physiology, mathematics and biochemistry. QSP was formally defined as a discipline and endorsed in the NIH White Paper (Sorger et al., 2011) in 2011.
Tarek A Leil, Sergey eErmakov
doaj   +7 more sources

Quantitative systems pharmacology of the eye: Tools and data for ocular QSP [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2023
Good eyesight belongs to the most‐valued attributes of health, and diseases of the eye are a significant healthcare burden. Case numbers are expected to further increase in the next decades due to an aging society.
Lars Kuepfer   +2 more
doaj   +2 more sources

Industrialization of Quantitative Systems Pharmacology [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2019
Brian Topp   +2 more
doaj   +3 more sources

Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2019
The lack of standardization in the way that quantitative and systems pharmacology (QSP) models are developed, tested, and documented hinders their reproducibility, reusability, and expansion or reduction to alternative contexts.
Lourdes Cucurull‐Sanchez   +12 more
doaj   +6 more sources

Home - About - Disclaimer - Privacy